1 |
Defilipp Z |
2019, N Engl J Med, Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant |
226 |
Drug-Resistant bacteremia |
Case report |
2 |
Costello SP |
2019, JAMA, Effect of fecal microbiota transplantation on 8-Week remission in patients with ulcerative colitis: a randomized clinical trial |
214 |
Ulcerative colitis |
Clinical trial |
3 |
Routy B |
2018, Science, Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors |
203 |
Tumor |
Clinical trial |
4 |
Gopalakrishnan V |
2018, Science, Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients |
171 |
Tumor |
Clinical trial |
5 |
Halkjaer SI |
2018, Gut, Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomized, double-blind placebo-controlled study |
98 |
Irritable bowel syndrome |
Clinical trial |
6 |
Wilson BC |
2019, Front Cell Infect Microbiol, The super-donor phenomenon in fecal microbiota transplantation |
94 |
Super-donor |
Review |
7 |
Suez J |
2018, Cell, Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT |
87 |
Antibiotics-associated dysbiosis |
Clinical trial |
8 |
Wang YH |
2019, Nat Med, Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis |
87 |
Inhibitor-associated colitis |
Case report |
9 |
Bolyen E |
2019, Nat Biotechnol, Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 |
85 |
QIIME |
Analysis method |
10 |
allegretti jr |
2019, Lancet, The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications |
77 |
Faecal microbiota transplantation |
Review |
11 |
Paramsothy S |
2019, Gastroenterology, Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis |
76 |
Ulcerative colitis |
Clinical trial |
12 |
Ianiro G |
2018b, Aliment Pharmacol Ther, Randomized clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions |
73 |
Clostridium difficile infection |
Clinical trial |
13 |
Ianiro G |
2018a, United European Gastroenterol J, Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: a systematic review and meta-analysis |
73 |
Clostridium difficile infection |
Meta analysis (Review) |
14 |
Smillie CS |
2018, Cell Host Microbe, Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation |
73 |
Bacterial Engraftment and efficacy |
Clinical trial |
15 |
Zuo T |
2018,Gut, Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome |
73 |
Bacteriophage transfer and efficacy |
Clinical trial |
16 |
Defilipp Z |
2018, Blood Adv, Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity |
70 |
Allogeneic hematopoietic cell transplantation |
Clinical trial |
17 |
Kang DW |
2019, Sci Rep, Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota |
70 |
Autism |
Clinical trial |
18 |
Zhang Fm |
2018, Protein Cell, Microbiota transplantation: concept, methodology and strategy for its modernization |
70 |
Faecal microbiota transplantation |
Review |
19 |
El-salhy M |
2020, Gut, Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomized, double-blind, placebo-controlled study |
69 |
Irritable bowel syndrome |
Clinical trial |
20 |
Taur Y |
2018, Sci Transl Med, Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant |
69 |
Antibiotics-associated dysbiosis |
Clinical trial |